ANTARES PHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ewing, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

SEC filing history

Showing 326-350 of 688 matching filings.

Per page
25
Current page
14
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

ATRS-8K-20170314 EARNINGS RELESE

Filing date
14 Mar 2017
Reporting date
14 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

INVESTOR PRESENTATION

Filing date
06 Mar 2017
Reporting date
06 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-47575

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-47575

SC 13G/A filing

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

INVESTOR PRESENTATION

Filing date
27 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jan 2017
Reporting date
30 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Dec 2016
Reporting date
27 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Dec 2016
Reporting date
09 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Dec 2016
Reporting date
01 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-32302

ATRS-10Q-20160930

Filing date
09 Nov 2016
Reporting date
30 Sep 2016
Next action
Verify source filing
8-K File 001-32302

ATRS-8K-20151105

Filing date
09 Nov 2016
Reporting date
09 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Nov 2016
Reporting date
31 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Nov 2016
Reporting date
31 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

ITEM 5.02 APPOINTMENT OF PRINCIPAL OFFICERS

Filing date
01 Nov 2016
Reporting date
31 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

ATRS-INVESTOR PRESENTATION

Filing date
27 Sep 2016
Reporting date
27 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

ATRS-INVESTOR PRESENTATION

Filing date
14 Sep 2016
Reporting date
14 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
12 Sep 2016
Reporting date
04 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

ITEM 5.02

Filing date
07 Sep 2016
Reporting date
01 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

ITEM 5.02

Filing date
11 Aug 2016
Reporting date
05 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-32302

ATRS-10Q-20160630

Filing date
09 Aug 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
8-K File 001-32302

ATRS-8K-20160809

Filing date
09 Aug 2016
Reporting date
09 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-47575

SC 13G/A filing

Filing date
08 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .